4552 — JCR Pharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for JCR Pharmaceuticals Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	30,977	13,278	18,756	13,196	14,007
Net Total Accounts Receivable
Net Total Receivables	15,585	11,137	14,934	12,236	14,162
Total Inventory
Total Other Current Assets
Total Current Assets	62,188	47,802	57,581	51,056	56,076
Net Property, Plant And Equipment	26,782	32,681	30,040	37,410	39,244
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	97,134	94,937	102,226	104,855	109,236
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	42,054	35,762	30,135	43,988	48,135
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	46,250	42,775	46,048	57,812	62,294
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	50,884	52,162	56,178	47,043	46,942
Total Liabilities & Shareholders' Equity	97,134	94,937	102,226	104,855	109,236
Total Common Shares Outstanding